Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Faletti

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Biomedical Journal|August 9, 2021
Germline STAT3 gain-of-function mutations in primary immunodeficiency: Impact on the cellular and clinical phenotypeLaura Faletti, Stephan Ehl, Maximilian Heeg
Journal of Clinical Immunology|May 4, 2023
JAKs and STATs from a Clinical Perspective: Loss-of-Function Mutations, Gain-of-Function Mutations, and Their Multidimensional ConsequencesNils Ott, Laura Faletti, Maximilian Heeg, et al.
Virus Research|March 5, 2015
How do viruses control mitochondria-mediated apoptosis?Simon Neumann, Souhayla El Maadidi, Laura Faletti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2014
A novel mitochondrial MAVS/Caspase-8 platform links RNA virus-induced innate antiviral signaling to Bax/Bak-independent apoptosisSouhayla El Maadidi, Laura Faletti, Birgit Berg, et al.
Pediatric Pulmonology|September 22, 2021
Early-onset, fatal interstitial lung disease in STAT3 gain-of-function patientsFlorian Gothe, Jonathan Gehrig, Christina K Rapp, et al.
Cell Death & Disease|September 7, 2018
TNFα sensitizes hepatocytes to FasL-induced apoptosis by NFκB-mediated Fas upregulationLaura Faletti, Lukas Peintner, Simon Neumann, et al.
Science Signaling|February 20, 2024
Activation of gp130 signaling in T cells drives T<sub>H</sub>17-mediated multi-organ autoimmunityFrancis Baumgartner, Stefanos A Bamopoulos, Laura Faletti, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Biomedical Journal|August 9, 2021
Germline STAT3 gain-of-function mutations in primary immunodeficiency: Impact on the cellular and clinical phenotypeLaura Faletti, Stephan Ehl, Maximilian Heeg
Journal of Clinical Immunology|May 4, 2023
JAKs and STATs from a Clinical Perspective: Loss-of-Function Mutations, Gain-of-Function Mutations, and Their Multidimensional ConsequencesNils Ott, Laura Faletti, Maximilian Heeg, et al.
Virus Research|March 5, 2015
How do viruses control mitochondria-mediated apoptosis?Simon Neumann, Souhayla El Maadidi, Laura Faletti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2014
A novel mitochondrial MAVS/Caspase-8 platform links RNA virus-induced innate antiviral signaling to Bax/Bak-independent apoptosisSouhayla El Maadidi, Laura Faletti, Birgit Berg, et al.
Pediatric Pulmonology|September 22, 2021
Early-onset, fatal interstitial lung disease in STAT3 gain-of-function patientsFlorian Gothe, Jonathan Gehrig, Christina K Rapp, et al.
Cell Death & Disease|September 7, 2018
TNFα sensitizes hepatocytes to FasL-induced apoptosis by NFκB-mediated Fas upregulationLaura Faletti, Lukas Peintner, Simon Neumann, et al.
Science Signaling|February 20, 2024
Activation of gp130 signaling in T cells drives T<sub>H</sub>17-mediated multi-organ autoimmunityFrancis Baumgartner, Stefanos A Bamopoulos, Laura Faletti, et al.
Pageof 1